. 2017 Feb 28;11:126–132. doi: 10.2174/1874210601711010126
© 2017 Moeintaghavi et al.
This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International Public License (CC-BY 4.0), a copy of which is available at: https://creativecommons.org/licenses/by/4.0/legalcode. This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Fig. (1).
Oral-B CrossAction (Oral B®, Procter and Gamble Co., USA).